Citadel Advisors’s Iterum Therapeutics ITRM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-21,207
| Closed | -$37.5K | – | 6438 |
|
2024
Q4 | $37.5K | Buy |
+21,207
| New | +$37.5K | ﹤0.01% | 5523 |
|
2023
Q4 | – | Sell |
-19,566
| Closed | -$16.2K | – | 6292 |
|
2023
Q3 | $16.2K | Buy |
+19,566
| New | +$16.2K | ﹤0.01% | 5350 |
|
2022
Q2 | – | Sell |
-3,368
| Closed | -$18K | – | 6473 |
|
2022
Q1 | $18K | Buy |
3,368
+1,875
| +126% | +$10K | ﹤0.01% | 6153 |
|
2021
Q4 | $9K | Buy |
+1,493
| New | +$9K | ﹤0.01% | 6360 |
|
2021
Q3 | – | Sell |
-4,624
| Closed | -$160K | – | 6729 |
|
2021
Q2 | $160K | Sell |
4,624
-4,511
| -49% | -$156K | ﹤0.01% | 5717 |
|
2021
Q1 | $193K | Sell |
9,135
-1,554
| -15% | -$32.8K | ﹤0.01% | 5445 |
|
2020
Q4 | $159K | Buy |
10,689
+9,932
| +1,312% | +$148K | ﹤0.01% | 4574 |
|
2020
Q3 | $12K | Buy |
+757
| New | +$12K | ﹤0.01% | 4573 |
|